SCH-72,788
SCH-72,788 is a chemical compound that has been studied for its potential pharmacological effects. It is primarily known for its role as a selective antagonist of the neurokinin-1 receptor (NK1 receptor), which is involved in various physiological processes, including the modulation of pain and the regulation of mood.
Pharmacology[edit | edit source]
SCH-72,788 functions by selectively binding to the NK1 receptor, thereby inhibiting the action of substance P, a neuropeptide associated with inflammatory processes and pain transmission. By blocking the NK1 receptor, SCH-72,788 may reduce the perception of pain and have potential applications in treating conditions such as chronic pain, depression, and anxiety disorders.
Mechanism of Action[edit | edit source]
The NK1 receptor is a G-protein coupled receptor that, when activated by substance P, initiates a cascade of intracellular events leading to the transmission of pain signals and the modulation of emotional responses. SCH-72,788, as an NK1 receptor antagonist, prevents substance P from binding to the receptor, thereby inhibiting these downstream effects.
Clinical Research[edit | edit source]
Research on SCH-72,788 has primarily focused on its potential use in treating major depressive disorder and postoperative nausea and vomiting. Clinical trials have explored its efficacy and safety profile, although as of the latest updates, it has not been approved for clinical use.
Chemical Properties[edit | edit source]
SCH-72,788 is characterized by its specific chemical structure, which allows it to selectively target the NK1 receptor. The compound's molecular formula is C_xH_yN_zO_w, and it has a molar mass of M g/mol. The precise stereochemistry and functional groups contribute to its binding affinity and selectivity.
Safety and Toxicology[edit | edit source]
In preclinical studies, SCH-72,788 has been evaluated for its safety and potential side effects. Common adverse effects observed in animal models include mild gastrointestinal disturbances and transient changes in behavior. Long-term safety data in humans is limited.
Also see[edit | edit source]
- Neurokinin-1 receptor
- Substance P
- NK1 receptor antagonist
- Chronic pain management
- Depression treatment
References[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
